Get started
Author

Kurt Püchler

The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction
2001 · Petra Laeis, Kurt Püchler, et al. · Journal of Hypertension · 156
Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil
2001 · Klaus von Bergmann, Petra Laeis, et al. · Journal of Hypertension · 68
Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist
2001 · Kurt Püchler, Petra Laeis, et al. · Journal of Hypertension · 59
Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients
1997 · Kurt Püchler, Jürg Nussberger, et al. · Journal of Hypertension · 34
Haemolytic Transfusion Reactions Due to Hla Antibodies
1987 · Simon Panzer, WolfgangR. Mayr, et al. · The Lancet · 28
Value of Different Clinical and Biochemical Correlates to Assess Angiotensin Converting Enzyme Inhibition
1994 · Etienne Delacrétaz, Jürg Nussberger, et al. · Journal of Cardiovascular Pharmacology · 17
The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects
1997 · Kurt Püchler, Klaus Schaffler, et al. · International Clinical Psychopharmacology · 15
The effects of RS-8359 on cardiovascular function in healthy subjects and depressed patients
1997 · Astrid Plenker, Kurt Püchler, et al. · International Clinical Psychopharmacology · 15
Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients
1998 · K. Püchler, B. Sierakowski, et al. · British Journal of Clinical Pharmacology · 11
Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment
1997 · K. Püchler, K. M. Eckl, et al. · British Journal of Clinical Pharmacology · 6
PDF
The pharmacokinetic profile of RS-8359
1997 · Kurt Püchler, Kunihiro Sasahara, et al. · International Clinical Psychopharmacology · 5
Comparison of Temocapril and Atenolol in the Long-term Treatment of Mild to Moderate Essential Hypertension
1997 · Bernd Sierakowski, Kurt Püchler, et al. · Blood Pressure · 5
PDF
Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS-8359
1997 · Nobuyoshi Iwata, Kurt Püchler, et al. · International Clinical Psychopharmacology · 4
Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
1997 · B. Sierakowski, K. Püchler, et al. · European Journal of Clinical Pharmacology · 3
Project Management Opportunities and Challenges in Central and Eastern Europe
2005 · Kurt Püchler, Jörg Rennecke · Drug Information Journal · 2
Safety, tolerability and efficacy of the reversible monoamine oxidase inhibitor RS-8359 in early clinical trials
1997 · Kurt Püchler, Astrid Plenker, et al. · International Clinical Psychopharmacology · 2
Combination Therapy of Olmesartan Medoxomil With Amlodipine or Atenolol Maintains Steady State Pharmacokinetics of Each Drug Unchanged
2004 · R. Kreutz, K. Püchler, et al. · Journal of Hypertension
The Effect of the Combination of the Oral Angiotensin Ii-antagonist Olmesartan Medoxomil and Glibenclamide on Pharmacokinetics, Safety and Tolerability in Healthy Male Subjects
2004 · R. Kreutz, K. Püchler, et al. · Journal of Hypertension
Similarities and Differences between the United States and Europe in the Development of Fixed Combination Products for the Treatment of Hypertension
2001 · John Alexander, Kurt Püchler · Drug Information Journal
P.1.098 Early phase II results of the RIMA RS-8359
1997 · K. Püchler, A. Plenker, et al. · European Neuropsychopharmacology
P.1.095 Clinical pharmacological profile of the RIMA RS-8359
1997 · A. Plenker, K. Püchler, et al. · European Neuropsychopharmacology
Pharmacokinetics and pharmacodynamics of the new reversible MAO-A inhibitor RS-8359
1997 · A. Plenker, K. Puechler, et al.
The safety and tolerability profile of a new RIMA antidepressant, RS-8359 in healthy subjects and depressed patients
1996 · K. Puechler, A. Plenker, et al. · European Neuropsychopharmacology
The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects
1996 · K. Puechler, K. Schaffler, et al. · European Neuropsychopharmacology
The effects of a new RIMA antidepressant RS-8359 on cardiovascular function
1996 · K. Puechler, A. Plenker, et al. · European Neuropsychopharmacology
Works count: 25
Citation count: 430
H-index: 9
I10-index: 9
Year
Topic
Type